DKA & ESRD - Nursing Case Study
Pathophysiology
Diabetic Ketoacidosis (DKA):
• Primary mechanism: Insulin deficiency leads to elevated blood glucose, causing hyperglycemia as cells cannot uptake glucose efficiently.
• Secondary mechanism: Increased lipolysis and free fatty acid oxidation result in ketone production, leading to metabolic acidosis.
• Key complication: Electrolyte imbalances, particularly hypokalemia, can occur due to increased renal excretion and intracellular shifts.
End-Stage Renal Disease (ESRD):
• Primary mechanism: Progressive nephron loss reduces glomerular filtration rate, leading to the accumulation of waste products like urea and creatinine in the blood.
• Secondary mechanism: Compensatory mechanisms fail, causing imbalances in electrolytes, fluid retention, and hypertension.
• Key complication: Uremia, characterized by systemic symptoms due to toxin accumulation, can affect multiple organ systems.
Patient Profile
Demographics:
56-year-old female, retired teacher
History:
• Key past medical history: Type 1 Diabetes Mellitus, Hypertension, End-Stage Renal Disease (ESRD), Diabetic Retinopathy
• Current medications: Insulin glargine, insulin lispro, Lisinopril, Erythropoietin, Phosphate binders
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Nausea and abdominal pain
• Key symptoms: Polyuria, polydipsia, fatigue, shortness of breath, confusion, muscle cramps
• Vital signs: Temperature 99.5°F, Heart Rate 110 bpm, Respiratory Rate 28 breaths per minute, Blood Pressure 150/90 mmHg, Oxygen Saturation 92% on room air
Section 1
As the nursing team conducts an initial assessment, several critical findings emerge that necessitate immediate attention. The patient's blood glucose level is significantly elevated at 450 mg/dL, confirming the suspicion of DKA. Arterial blood gas analysis reveals a pH of 7.25, indicating metabolic acidosis, while the serum bicarbonate level is markedly low at 14 mEq/L. Further laboratory results show elevated serum potassium at 5.8 mEq/L, although this may be misleading due to intracellular shifts associated with acidosis. The elevated anion gap of 20 mEq/L corroborates the presence of ketoacidosis. The patient's serum creatinine is elevated at 6.5 mg/dL, reflecting her underlying ESRD, and blood urea nitrogen (BUN) is 85 mg/dL, indicating significant renal impairment.
The patient's condition is further complicated by her respiratory status. She exhibits Kussmaul respirations, a compensatory mechanism for metabolic acidosis, indicated by her increased respiratory rate and deep, labored breathing pattern. Despite this, her oxygen saturation remains low at 92% on room air, suggesting potential compromise in gas exchange or additional factors affecting her respiratory status. The patient reports persistent shortness of breath and fatigue, which may be exacerbated by fluid overload due to her renal condition. Auscultation of the lungs reveals crackles at the bases, hinting at possible pulmonary congestion or edema.
Given these findings, the clinical team prioritizes stabilizing the patient's metabolic derangements and addressing her respiratory distress. Fluid resuscitation with isotonic saline is initiated to correct dehydration, along with intravenous insulin to reduce hyperglycemia and ketone production. Continuous cardiac monitoring is essential due to the risk of arrhythmias associated with fluctuating potassium levels. Additionally, the potential need for urgent dialysis is considered to address significant uremia and fluid overload, as the patient shows signs of worsening renal function and systemic toxin accumulation. This integrated approach aims to optimize her condition and prevent further complications as her clinical journey progresses.
Section 2
As the clinical team implements the initial interventions, the patient's condition is closely monitored for any changes or new complications. After several hours of treatment, the patient's blood glucose level begins to decrease gradually, reaching 300 mg/dL. Despite this improvement, the patient remains in metabolic acidosis, with a repeat arterial blood gas showing a pH of 7.30 and a serum bicarbonate level still low at 16 mEq/L. Although there is progress, the acidosis has not fully resolved, suggesting ongoing ketoacid production or insufficient bicarbonate regeneration.
Concurrently, the patient's respiratory status shows subtle signs of deterioration. Her oxygen saturation decreases to 88% on room air, and she becomes more tachypneic, with a respiratory rate climbing to 30 breaths per minute. The crackles on lung auscultation have become more pronounced, now audible throughout the lower lung fields. These findings raise concern for worsening pulmonary edema, likely exacerbated by fluid resuscitation and her compromised renal function. The patient's jugular venous distention is noted to be more prominent, indicating possible right-sided heart strain or fluid overload.
Given these developments, the clinical team reassesses the need for urgent dialysis to address fluid overload and persistent metabolic derangements. The risk of respiratory compromise due to pulmonary congestion necessitates prompt intervention. In addition, the team considers adjusting the fluid management plan to balance hydration with the prevention of further overload. Continuous monitoring and targeted therapy are crucial to stabilize the patient's condition, prevent further complications, and guide the next steps of her treatment plan.
Section 3
As the clinical team reassesses the patient's condition, they decide to initiate urgent dialysis to manage the fluid overload and persistent metabolic acidosis. The nephrology team is consulted, and a temporary dialysis catheter is placed for immediate hemodialysis. The patient's vital signs are monitored closely, revealing a blood pressure of 160/95 mmHg, potentially indicating fluid overload or stress response. Despite the initiation of dialysis, the patient remains tachypneic with a respiratory rate of 30 breaths per minute and oxygen saturation hovering around 88% on room air, necessitating supplemental oxygen via nasal cannula to maintain SpO2 above 92%.
In parallel, new diagnostic results reveal a worsening anion gap metabolic acidosis with an anion gap of 20, signifying ongoing ketoacid accumulation despite insulin therapy. Serum potassium, initially elevated, has now dropped to 3.2 mEq/L due to both insulin therapy and the dialysis process, necessitating careful potassium replacement to avoid complications of hypokalemia. The patient's lactate level has increased slightly to 3.5 mmol/L, suggesting a component of lactic acidosis possibly due to tissue hypoxia or decreased clearance secondary to renal dysfunction.
The patient's respiratory status continues to be a primary concern. A chest X-ray confirms bilateral pulmonary edema, consistent with fluid overload, though there is no evidence of infectious infiltrates. The clinical team carefully adjusts the fluid management plan, reducing the rate of IV fluid administration while closely monitoring urine output and hemodynamic status. As dialysis progresses, the patient's respiratory rate begins to decrease slightly, and her oxygen saturation improves to 91% on supplemental oxygen, indicating a positive response to fluid removal. The team remains vigilant for potential hemodynamic instability post-dialysis and prepares to reassess the patient's acid-base status and electrolytes promptly to guide further interventions.
Section 4
As the dialysis session progresses, the patient's respiratory rate continues to decrease, reaching 26 breaths per minute, and her oxygen saturation stabilizes at 93% with supplemental oxygen. However, new concerns arise as the patient's blood pressure drops to 105/65 mmHg post-dialysis, suggesting potential fluid shifts and hemodynamic changes. The clinical team, mindful of the risk of hypovolemia, decides to cautiously administer a small fluid bolus while closely monitoring the patient's response. Concurrently, the nephrology team reassesses the patient's electrolyte status, noting a further decrease in serum potassium to 2.8 mEq/L, necessitating urgent potassium supplementation to prevent arrhythmias and muscle weakness.
New diagnostic results reveal an improvement in the metabolic acidosis, with the anion gap narrowing to 16, indicating a partial resolution of ketoacid accumulation. Despite this improvement, the patient exhibits signs of increased fatigue and confusion, raising concerns about potential cerebral edema or other neurological complications. A neurological assessment is conducted, revealing mild disorientation and sluggish pupillary response, prompting the team to order a CT scan of the head to rule out intracranial abnormalities.
As the patient continues to recover from the acute phase of her condition, the clinical team remains focused on optimizing her care. They adjust the insulin regimen to maintain blood glucose levels within a target range while ensuring adequate potassium replacement to address hypokalemia. The team also plans for ongoing dialysis sessions to manage her end-stage renal disease and prevent further fluid overload. Regular assessments of the patient's neurological status and acid-base balance are prioritized to detect and address any new complications swiftly. This comprehensive approach aims to stabilize the patient's condition and facilitate her transition to a more stable state.
Section 5
The CT scan of the head returns with no acute intracranial abnormalities, providing some reassurance to the clinical team. However, the patient's neurological status remains a concern as she continues to exhibit increased fatigue and confusion. Her Glasgow Coma Scale score is slightly decreased at 13, with mild disorientation and delayed verbal responses. To address these neurological symptoms, the team considers the potential for osmotic shifts due to rapid changes in glucose levels and electrolyte imbalances. They decide to perform a lumbar puncture to rule out any infectious causes of her altered mental status, such as meningitis, while continuing to monitor her closely for signs of cerebral edema.
In parallel, the nephrology and critical care teams collaboratively reassess the patient's hemodynamic status and electrolyte management. Her blood pressure remains on the lower side, now at 100/60 mmHg, despite the fluid bolus, indicating a persistent risk of hypovolemia. The team decides to administer another cautious fluid challenge while ensuring that her potassium levels are gradually corrected. Follow-up labs show a slight improvement in potassium levels, now at 3.1 mEq/L, but highlight the need for continued potassium replacement and careful monitoring to avoid cardiac complications.
As the clinical team implements these targeted interventions, they remain vigilant for any new complications that could arise. The primary focus is on achieving a delicate balance between managing her electrolyte imbalances, maintaining hemodynamic stability, and addressing her neurological symptoms. Through regular assessments and timely adjustments to her treatment plan, the team aims to stabilize her condition further, ultimately facilitating her recovery and preparation for ongoing management of her end-stage renal disease and diabetes.